144 related articles for article (PubMed ID: 33625084)
1. Therapy-related Myeloid Neoplasms in Children: A Single-institute Study.
Li G; Holly T; Kelly DR; Reddy V; Mikhail FM; Carroll AJ; Kutny MA
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e109-e113. PubMed ID: 33625084
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related myeloid neoplasms in 39 Korean patients: a single institution experience.
Huh HJ; Lee SH; Yoo KH; Sung KW; Koo HH; Kim K; Jang JH; Jung C; Kim SH; Kim HJ
Ann Lab Med; 2013 Mar; 33(2):97-104. PubMed ID: 23483787
[TBL] [Abstract][Full Text] [Related]
3. The p53 gene in pediatric therapy-related leukemia and myelodysplasia.
Felix CA; Hosler MR; Provisor D; Salhany K; Sexsmith EA; Slater DJ; Cheung NK; Winick NJ; Strauss EA; Heyn R; Lange BJ; Malkin D
Blood; 1996 May; 87(10):4376-81. PubMed ID: 8639798
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
5. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
Side LE; Curtiss NP; Teel K; Kratz C; Wang PW; Larson RA; Le Beau MM; Shannon KM
Genes Chromosomes Cancer; 2004 Mar; 39(3):217-23. PubMed ID: 14732923
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome.
Talwalkar SS; Yin CC; Naeem RC; Hicks MJ; Strong LC; Abruzzo LV
Arch Pathol Lab Med; 2010 Jul; 134(7):1010-5. PubMed ID: 20586629
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutation.
Chantrain CF; Jijon P; De Raedt T; Vermylen C; Poirel HA; Legius E; Brichard B
Pediatr Blood Cancer; 2007 Jan; 48(1):101-4. PubMed ID: 16078230
[TBL] [Abstract][Full Text] [Related]
8. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study.
de Andrade KC; Khincha PP; Hatton JN; Frone MN; Wegman-Ostrosky T; Mai PL; Best AF; Savage SA
Lancet Oncol; 2021 Dec; 22(12):1787-1798. PubMed ID: 34780712
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
11. Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective.
Shin SJ; Dodd-Eaton EB; Gao F; Bojadzieva J; Chen J; Kong X; Amos CI; Ning J; Strong LC; Wang W
Cancer Res; 2020 Jan; 80(2):347-353. PubMed ID: 31719099
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer.
Epstein-Peterson ZD; Devlin SM; Stein EM; Klimek VM; Saltz LB; Tallman MS
Leuk Res; 2019 Jul; 82():19-23. PubMed ID: 31151028
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study.
Hendrickson PG; Luo Y; Kohlmann W; Schiffman J; Maese L; Bishop AJ; Lloyd S; Kokeny KE; Hitchcock YJ; Poppe MM; Gaffney DK; Tao R
Cancer Med; 2020 Nov; 9(21):7954-7963. PubMed ID: 32931654
[TBL] [Abstract][Full Text] [Related]
14. An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome?
Archer NM; Amorim RP; Naves R; Hettmer S; Diller LR; Ribeiro KB; Rodriguez-Galindo C
Pediatr Blood Cancer; 2016 Feb; 63(2):196-201. PubMed ID: 26193998
[TBL] [Abstract][Full Text] [Related]
15. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
16. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.
Jerez A; Gondek LP; Jankowska AM; Makishima H; Przychodzen B; Tiu RV; O'Keefe CL; Mohamedali AM; Batista D; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
J Clin Oncol; 2012 Apr; 30(12):1343-9. PubMed ID: 22370328
[TBL] [Abstract][Full Text] [Related]
17. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
18. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
[TBL] [Abstract][Full Text] [Related]
19. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
20. A monocentric retrospective study of 138 therapy-related myeloid neoplasms.
Claerhout H; Lierman E; Michaux L; Verhoef G; Boeckx N
Ann Hematol; 2018 Dec; 97(12):2319-2324. PubMed ID: 30203335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
